Related Experiment Video
Updated: Jun 17, 2026
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Chronic hepatitis C virus infection in children
Neelam Mohan1, Regino P González-Peralta, Tomoo Fujisawa
1Department of Pediatrics, Centre of Child Health, Sir Ganga Ram Hospital, New Delhi, India.
Journal of Pediatric Gastroenterology and Nutrition
|December 30, 2009
Summary
Hepatitis C viral infection in children is increasingly recognized, with better understanding of its spread and disease progression. Current monitoring, treatment, and emerging therapies are reviewed for pediatric care.
Area of Science:
- Pediatric infectious diseases
- Hepatology
- Viral immunology
Background:
- Hepatitis C virus (HCV) infection in children is a growing public health concern.
- Increased knowledge of HCV epidemiology and pediatric disease progression is available.
- Therapeutic options for pediatric hepatitis C are expanding.
Purpose of the Study:
- To provide an updated overview of pediatric hepatitis C infection.
- To present current recommendations for monitoring and treatment.
- To discuss novel and emerging therapeutic strategies for children.
Main Methods:
- Literature review of recent studies on pediatric hepatitis C.
- Analysis of current clinical guidelines for HCV management in children.
- Review of emerging treatments and research in the field.
Main Results:
- Updated understanding of HCV epidemiology in pediatric populations.
- Current evidence-based recommendations for monitoring and treatment.
- Overview of promising new therapies under investigation.
Conclusions:
- Pediatric hepatitis C requires ongoing attention and updated management strategies.
- Early diagnosis and appropriate treatment are crucial for long-term outcomes.
- Emerging therapies hold promise for improved treatment efficacy and safety in children.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...